Effect of Vitamin D3 Supplementation in Treatment of Irritable Bowel Syndrome

NCT ID: NCT02579902 Phase: PHASE1 Status: COMPLETED Enrollment: 90 Completion: 2015-09

Conditions

Irritable Bowel Syndrome

Interventions

Vitamin D3 (Cholecalciferol), placebo

Summary

The purpose of this study is to determine whether vitamin D3 supplementation is effective in the treatment of clinical signs, biomarkers of inflammation and oxidative stress due to Irritable Bowel Syndrome (IBS).

Primary Outcome

Clinical signs including abdominal pain, bloating, rumbling, abdominal distention, dissatisfaction with stool consistency

Source

ClinicalTrials.gov